Company Overview and News

 
Closing Bell: Global cues push Sensex, Nifty higher; midcaps outperform

2018-04-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher despite crude oil prices, backed by metals, technology and FMCG stocks.
Upvote Downvote

 
Market Live: TCS up 1% ahead of Q4 nos, Welspun Corp gains 5% on order win

2018-04-19 moneycontrol
"The state-of-the-art facility enables Honeywell to provide enhanced expertise and training capabilities to customers and expand its production range," the company said.
Upvote Downvote

 
Market Live: Sensex, Nifty continue to trade higher; IndusInd falls 2% post Q4, RIL gains

2018-04-19 moneycontrol
1:52 pm Market Update: The market continued to trade mildly higher, with support from metals, technology and FMCG stocks. It shrugged off higher crude oil prices.
Upvote Downvote

 
Market Live: Nifty holds 10,550 amid consolidation; TCS, HCL, Tech Mahindra rally

2018-04-19 moneycontrol
12:55 pm Buzzing: Allied Digital was locked at 10 percent upper circuit after one-time settlement of its dues to State Bank of India for Rs 60.34 crore.
Upvote Downvote

 
Market Live: Sensex continues to trade higher on global cues; IOC, HPCL, BPCL dip 3-5%

2018-04-19 moneycontrol
774 crore for the construction of third rail line between Jimidipeta and Gotlam on East Coast Railway on engineering, procurement and construction (EPC) basis.
Upvote Downvote

 
Market Live: Sensex trades higher even as Brent crude hits $74/bbl; Metal index up 2%

2018-04-19 moneycontrol
9:59 am Buzzing: Mindtree share price gained 3 percent after the company reported a 28.8 percent sequential growth in profit at Rs 182.2 crore and6.3 percent in revenue at Rs 1,464 crore for the quarter ended March 2018.
Upvote Downvote

 
Market Live: Sensex up 100 pts despite Brent crude hits $74/bbl; Metal index up 2%

2018-04-19 moneycontrol
9:50 am Market Update: The market traded higher despite the sharp upmove in crude oil prices, following positive lead from global peers. Investors closely monitor March quarter earnings to get further market direction.
Upvote Downvote

 
Closing Bell: Sensex, Nifty close lower; banks drag but FMCG stocks support

2018-04-18 moneycontrol
3:30 pm Market Closing: Benchmark indices closed lower for the first time in last 10 consecutive sessions, dragged by banks. However, the upside in ITC capped losses.
Upvote Downvote

 
Market Live: Sensex erases gains, Nifty below 10,550; banks under pressure

2018-04-18 moneycontrol
1:55 pm Earnings: Mastek's Q4 consolidated net profit increased to Rs 19.4 crore from Rs 18.4 crore and revenue grew by 6.8 percent to Rs 223.7 crore on sequential basis.
Upvote Downvote

 
Market Live: Sensex extends gains, Nifty inches towards 10,600; ITC leads

2018-04-18 moneycontrol
1:18 pm Market Update: Benchmark indices extended gains in afternoon trade, with the Nifty inching towards 10,600 levels on hopes of strong earnings growth.
Upvote Downvote

 
Market Live: Nifty holds 10,550; FMCG index up 2%, Bharti Group stocks gain

2018-04-18 moneycontrol
12:55 pm Earnings Outlook: "We are looking at Sensex earnings. In Q4, earnings will grow in the range of 13-14 percent, which will be double digit growth after a long time. Partially, this will be due to low base of Q4 last year and the other due to better earnings of global commodity companies, be it energy or metals. That will aid overall growth,” Gaurav Dua, Head of Research, Sharekhan told Moneycontrol.
Upvote Downvote

 
Godrej Consumer Products Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-04-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Closing Bell: Sensex rises 578 pts, Nifty above 10,300 as RBI holds policy rates, cuts inflation forecast

2018-04-05 moneycontrol
3:30 pm Market Closing: Benchmark indices closed sharply higher on Thursday, with the Sensex rising 577.73 points or 1.75 percent to 33,596.80, and the Nifty gaining 196.80 points or 1.94 percent at 10,325.20.
Upvote Downvote

 
Markets are at high-value zone, say Kotak and BofA-Merrill Lynch

2018-03-27 thehindubusinessline
Our Bureau Benchmark Nifty 50 is down 4 per cent till date in 2018 (despite today’s sharp bounce back) thanks to th recent correction on account of global and domestic factors. Experts feel that the markets will continue to remain on tenterhooks as valuations are still high and the domestic macro environment has deteriorated (higher bond yields, oil, current account deficits).
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 00B1BDGY0